Amyotrophic Lateral Sclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
RanGAP physically interacts with HRE RNA and is mislocalized in HRE-expressing flies, neurons from C9orf72 ALS patient-derived induced pluripotent stem cells (iPSC-derived neurons), and in C9orf72 ALS patient brain tissue.
|
26308891 |
2015 |
Cystic Fibrosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Single sperm typing can address questions about segregation distortion in man, and it is unlikely that sex ratio distortion for CF carriers is due to events which occur pre-fertilisation.
|
7684944 |
1993 |
Fragile X Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
Such a segregation distortion is difficult to assess for the fra(X) syndrome because of incomplete penetrance, variable expression and probable ascertainment biases.
|
3177475 |
1988 |
Malignant neoplasm of stomach
|
0.010 |
Biomarker
|
disease |
BEFREE |
Additionally, circ-RanGAP1 silencing remarkably suppressed tumor growth and metastasis of GC in vivo.
|
31811909 |
2020 |
Narcolepsy
|
0.010 |
Biomarker
|
disease |
BEFREE |
These data show that there is no significant segregation distortion of the DR2/DQw1 haplotype in Japanese patients with narcolepsy.
|
3263961 |
1988 |
Neoplasm Metastasis
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Additionally, circ-RanGAP1 silencing remarkably suppressed tumor growth and metastasis of GC in vivo.
|
31811909 |
2020 |
Schizophrenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
These results indicate that antioxidant defence is altered in the schizophrenic hippocampus and suggest that segregation distortion, of schizophrenia susceptibility genes, may be a possible causative factor in the high incidence of schizophrenia.Molecular Psychiatry (2000) 5, 85-90.
|
10673773 |
2000 |
POLYDACTYLY, POSTAXIAL
|
0.010 |
Biomarker
|
disease |
BEFREE |
Segregation distortion in the offspring of Afro-American fathers with postaxial polydactyly.
|
7726178 |
1995 |
Pseudolymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Immunostaining showed that the majority of DLBCLs (92%, 46/50) were RanGAP1(+), while reactive lymphoid hyperplasia (n = 12) was RanGAP1(+) predominantly in germinal centers.
|
24223200 |
2013 |
Stomach Carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Additionally, circ-RanGAP1 silencing remarkably suppressed tumor growth and metastasis of GC in vivo.
|
31811909 |
2020 |
Learning Disabilities
|
0.010 |
Biomarker
|
disease |
BEFREE |
FRAXA and FRAXE: evidence against segregation distortion and for an effect of intermediate alleles on learning disability.
|
9435259 |
1998 |
Adult Diffuse Large B-Cell Lymphoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Ran GTPase-activating protein 1 is a therapeutic target in diffuse large B-cell lymphoma.
|
24223200 |
2013 |
Cone-Rod Dystrophy 2
|
0.010 |
Biomarker
|
disease |
BEFREE |
Analysis of a large cone-rod dystrophy pedigree suggested that inheritance within the family was influenced by meiotic drive (p = 0.008), a rare segregation distortion in human genetics.
|
8162077 |
1994 |
Cone-Rod Dystrophies
|
0.010 |
Biomarker
|
disease |
BEFREE |
Analysis of a large cone-rod dystrophy pedigree suggested that inheritance within the family was influenced by meiotic drive (p = 0.008), a rare segregation distortion in human genetics.
|
8162077 |
1994 |
Rod-Cone Dystrophy
|
0.010 |
Biomarker
|
disease |
BEFREE |
Analysis of a large cone-rod dystrophy pedigree suggested that inheritance within the family was influenced by meiotic drive (p = 0.008), a rare segregation distortion in human genetics.
|
8162077 |
1994 |
Episodic Kinesigenic Dyskinesia 1
|
0.010 |
Biomarker
|
disease |
BEFREE |
The main purpose of the study was to determine if PKD shows any segregation distortion and to obtain new estimates of the age-dependent penetrance.
|
8349100 |
1993 |
leukemia
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
Childhood Leukemia
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
Burkitt Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
Glioma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Inhibition of RNA transportation induces glioma cell apoptosis via downregulation of RanGAP1 expression.
|
25746355 |
2015 |
Hodgkin Disease
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
B-Cell Lymphomas
|
0.010 |
AlteredExpression
|
group |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
Adult Hodgkin Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
Childhood Hodgkin Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |
Adult Burkitt Lymphoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
RanGAP1 was also highly expressed in other B-cell lymphomas (BCL, n = 180) with brisk mitotic activity (B-lymphoblastic lymphoma/leukemia: 93%, and Burkitt lymphoma: 95%) or cell-cycle dysregulation (mantle cell lymphoma: 83%, and Hodgkin's lymphoma 91%).
|
24223200 |
2013 |